Current role of prostate-specific membrane antigen-based imaging and radioligand therapy in castration-resistant prostate cancer

Castration-resistant prostate cancer (CRPC) is a therapy-resistant and lethal form of prostate cancer as well as a therapeutic challenge. Prostate-specific membrane antigen (PSMA) has been proved as a promising molecular target for optimizing the theranostics for CRPC patients. When combined with PS...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiaxian, Qi, Lin, Tang, Yongxiang, Tang, Guyu, Gan, Yu, Cai, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411749/
https://www.ncbi.nlm.nih.gov/pubmed/36036001
http://dx.doi.org/10.3389/fcell.2022.958180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411749/
https://www.ncbi.nlm.nih.gov/pubmed/36036001
http://dx.doi.org/10.3389/fcell.2022.958180

Ejemplares similares